Skip to Main Content
Share
Help
Email
Print
Close Window
National Coverage Analysis (NCA) for Positron Emission Tomography (FDG) for Breast Cancer (CAG-00094N)
Contact(s)
Stuart Caplan, RN, MAS
Stuart.Caplan@cms.hhs.gov
410-786-8564
Back to Top
Documents
Tracking Sheet
Technology Assessment for FDG Positron Emission Tomography for Evaluating Breast Cancer
Decision Memo
NCD for Positron Emission Tomography (PET) Scans (220.6)
NCD for FDG PET for Breast Cancer (220.6.10)
NCD for Positron Emission Tomography (FDG) for Oncologic Conditions (220.6.17)
MEDCAC Meeting for Positron Emission Tomography (FDG) for Breast Cancer (Diagnostic Imaging Panel)
MEDCAC Meeting for Levocarnitine for End Stage Renal Disease & Positron Emission Tomography (FDG) for Breast Cancer (Executive Committee)
Back to Top
History of Considerations
Original Consideration for Positron Emission Tomography (FDG) for Breast Cancer (this document)
Back to Top
Footer Links
Get Help with File Formats and Plug-Ins
Submit Feedback
www
